Skip Navigation

JNCI Journal of the National Cancer Institute 2001 93(19):1447-1448;
© 2001 by Oxford University Press
This Article
Right arrow Extract Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Search for Related Content
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of the National Cancer Institute, Vol. 93, No. 19, 1447-1448, October 3, 2001
© 2001 Oxford University Press


NEWS

Awards, Appointments, Announcements

Richard Klausner, M.D., stepped down from his position as director of the National Cancer Institute. His resignation was effective Sept. 30.



View larger version (143K):
[in this window]
[in a new window]
 
Dr. Richard Klausner

 
Klausner will become the first president of the Case Institute of Health, Science, and Technology, a new venture formed by the Case Foundation, the family foundation of AOL Time Warner chairman Steve Case. The foundation will be located in the Washington, D.C., area.

According the Case Foundation, the new institute will "facilitate the generation of new ideas and solutions across the boundaries of traditional scientific disciplines; develop partnerships with academic, philanthropic, for-profit and other organizations; fund pilot projects; and launch and fund new initiatives not specific to any single disease."

At press time, U.S. Secretary of Health and Human Services Tommy Thompson had not yet named an acting director for NCI. The NCI director is a presidential appointment.

Rosenblatt Joins Faculty

Joseph D. Rosenblatt, M.D., has joined the faculty of the University of Miami School of Medicine as the William J. Harrington, M.D., Chair in Hematology; chief of the Division of Hematology/Oncology in the Department of Medicine; and as scientific director of UM/Sylvester Comprehensive Cancer Center.



View larger version (128K):
[in this window]
[in a new window]
 
Dr. Joseph D. Rosenblatt

 
Prior to joining UM/Sylvester, Rosenblatt was the chief of the Hematology/Oncology division at the University of Rochester and associate director for clinical research at the James P. Wilmot Cancer Center.

Hayes To Lead Program

Daniel F. Hayes, M.D., has joined the staff of the University of Michigan Comprehensive Cancer Center as the new clinical director of its Breast Oncology Program.



View larger version (139K):
[in this window]
[in a new window]
 
Dr. Daniel F. Hayes

 
Hayes, who also serves as a professor in the Department of Internal Medicine of the U-M Medical School, will be responsible for directing clinical services and overseeing the translation of basic breast cancer research into clinical trials.

Prior to joining the U-M staff, he was at Georgetown University, Washington, D.C.

Leone Honored

Gustavo W. Leone, Ph.D., of the Ohio State University Comprehensive Cancer Center, Columbus, has been named a 2001 Pew Scholar in the Biomedical Sciences.

Leone will be given $240,000 over 4 years to continue his work on developing tumor models for breast cancer.

Leone is a member of the Department of Molecular Virology, Immunology, and Medical Genetics. The award is given to 20 young scientists nationwide by the Pew Charitable Trusts.

Dickson Prize Awarded

Robert G. Roeder, Ph.D., professor and head of the Laboratory of Biochemical and Molecular Biology at Rockefeller University, New York, received the 2001 Dickson Prize in Medicine. The Dickson Prize is awarded by the University of Pittsburgh School of Medicine.

Roeder was honored for his work in the functional characterization of three eukaryotic RNA polymerases.

Call for Nominations

The International Union Against Cancer is accepting nominations for the Múcio Athayde Cancer Prize 2002, which will be awarded at the UICC Council meeting next June in Oslo, Norway.

The prize of a gold medal and $100,000 is given to a medically or scientifically qualified candidate who has made a major discovery or a contribution with global impact in the areas of basic or clinical cancer research, cancer control, or epidemiology.

The deadline for nominations is Dec. 31. More details are available at http://www.uicc.org/athaydeprize.

Fellowship Applications Available

The International Union Against Cancer is accepting applications for the UICC International Fellowships for Beginning Investigators.

The fellowships are funded by the American Cancer Society with the objective of fostering a bi-directional flow of knowledge, experience, expertise, and innovation between countries. These 12-month fellowships are intended for beginning investigators and clinicians who are in the early stages of their careers.

Eligible candidates should hold assistant professorships or similar positions at their home institutes and have a minimum of two and a maximum of 10 years of postdoctoral experience after obtaining their M.D. or Ph.D. degrees or equivalents.

Fellows selected receive an average of $40,000 for travel and stipend support. Completed applications are due by Dec. 1, 2001. Applications are available from the International Union Against Cancer, 3 rue Conseil-Général, 1205 Geneva, Switzerland, (4122) 809 18 40, fax: (4122) 809 18 10; http://fellows.uicc.org/.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?



This Article
Right arrow Extract Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Search for Related Content
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?